Anzeige
Mehr »
Dienstag, 08.07.2025 - Börsentäglich über 12.000 News
EchoIQ von 3 Analysehäusern als "Best-in-Class" bewertet - Kurszielpotenzial von über 200?%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUQT | ISIN: DK0061155009 | Ticker-Symbol:
1-Jahres-Chart
PHARMA EQUITY GROUP A/S Chart 1 Jahr
5-Tage-Chart
PHARMA EQUITY GROUP A/S 5-Tage-Chart

Aktuelle News zur PHARMA EQUITY GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.07.Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans1
28.05.Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns288Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns 28 May 2025Announcement no. 7 Pharma Equity Group (PEG) today announces the launch of a transformative...
► Artikel lesen
05.05.Passing of the General Meeting of Pharma Equity Group A/S234Passing of the General Meeting of Pharma Equity Group A/S 5th of May 2025Company Announcement no. 6 The chairman of the meeting reviewed the agenda for today's general meeting, which was: The Board...
► Artikel lesen
01.04.Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans1
PHARMA EQUITY GROUP Aktie jetzt für 0€ handeln
25.03.Notice convening the annual general meeting in Pharma Equity Group A/S2
20.03.Pharma Equity Group A/S - Annual Report 2024136Pharma Equity Group A/S - Annual Report 2024 Date: 20 March 2025 Announcement No. 2 Pharma Equity Group A/S - Annual Report 2024 - main features of the year The Board of Directors of Pharma Equity Group...
► Artikel lesen
28.02.Pharma Equity Group A/S: 2025 Financial Calendar1
14.01.Pharma Equity Group A/S: Pharma Equity Group 2025 Financial Calendar2
13.12.24Pharma Equity Group A/S: The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.94The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. December 13, 2024Announcement No. 32 Pharma Equity Group...
► Artikel lesen
15.11.24Pharma Equity Group A/S: Consolidated Interim report 1 January - 30 September 2024132Consolidated Interim report 1 January - 30 September 2024 Company announcement no. 30 - November 15, 2024 Key points from the Q1-Q3-2024 report (period 1 January - 30 September 2024) On 15 November...
► Artikel lesen
23.10.24Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.117Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. October 23, 2024Company Announcement...
► Artikel lesen
11.10.24Nasdaq Copenhagen A/S: Pharma Equity Group A/S - admittance to trading and official listing of new shares due to a directed issue341The share capital of Pharma Equity Group A/S has been increased. The admittance to trading and official listing of new shares will take effect as per 16 October 2024 in the ISIN below. ISIN ...
► Artikel lesen
04.10.24Nasdaq Copenhagen A/S: Pharma Equity Group A/S - reduction of share capital by reduction of face value per share211The changes below will take effect on Nasdaq Copenhagen as per 10 October 2024. ISIN DK0061155009 -------------------------------------------------------------------------------- Name:...
► Artikel lesen
16.08.24Pharma Equity Group A/S: Consolidated Interim Report 1 January - 30 June 2024170Consolidated Interim Report 1 January - 30 June 2024 Company announcement no. 23 - August 16, 2024 Key points from the H1-2024 report (period 1 January - 30 June 2024) On 16 August 2024, the...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1